(Reuters Health)—U.S. commercial health plans only covered biosimilar treatments as preferred products in 14% of coverage decisions last year, according to an analysis of publicly available data on coverage decisions.1 Researchers examined records from the Tufts Medical Center Specialty Drug Evidence and Coverage (SPEC) database, which has information on coverage decisions made by 17 of…
Search results for: health insurance
Some Telemedicine Barriers Are Down During COVID-19 Pandemic
Telerheumatology—which refers to the application of electronic communication technology to clinical encounters from a distance between rheumatologists and their patients—has the potential to extend a workforce projected to experience significant shortfalls, making it more accessible to more patients. Multiple barriers that stood in the way of taking full advantage of this promise are now down—at…
Capitol Hill Rheumatology Advocacy Goes Virtual
ACR volunteer leaders and staff will convene more than 100 meetings via teleconference with Congressional leaders on May 22, addressing rheumatology provider solvency and patient access to care amidst the COVID-19 pandemic.
Reimbursement Tips: Telemedicine & Coding in the Time of COVID-19
Humans may fear change as a general rule, but we’re adaptable when we need to be. In this era of COVID-19 and social distancing, medical practices and payers are adapting to an increased use of telemedicine, which enables providers to see their patients without being in a room with them. To cope, the Centers for…
How to Maintain Connections with Colleagues, Staff & Patients During a Pandemic: A Q&A with Reshma Khan, MD
As the cases of COVID-19 continue to rise in South Florida, Reshma Khan, MD, a rheumatologist at the Palm Beach Rheumatology and Wellness Center, Jupiter, Fla., is being careful to emphasize social distancing, but not social isolation. Dr. Khan believes that, during this pandemic, it’s more important than ever for rheumatologists to share support and…
The COVID-19 Crisis: Uncharted Waters & the ACR’s Response
Singer Jimmy Dean reportedly once said, “I can’t change the direction of the wind, but I can adjust my sails to always reach my destination.” The COVID-19 pandemic has required us as rheumatologists to adjust our sails multiple times. We have had to rethink many of the ways in which we interact with our worried…
Experts Offer Tips for Saving Time on Electronic Medical Records
ATLANTA—“Bane of our existence” and “pajama time”—the dreaded time spent at night catching up on documentation—are a couple of phrases associated with the electronic medical record (EMR). To try to ease the frustration and limit the amount of time physicians have to spend using the systems, two experts reviewed tools and tricks for Epic and…
Yes, the FDA Employs Rheumatologists. Here’s Their Role.
Ever wonder what role physician regulators—rheumatologists, in particular—perform at the U.S. Food & Drug Administration (FDA)? “I am not sure that many practicing rheumatologists know there are clinicians who work for the FDA,” says rheumatologist Nadia Habal, MD, a medical officer in the Division of Pulmonary, Allergy, and Rheumatology Products at the FDA. “It would…
The Personal Side of COVID-19: Q&A with Philip A. Waller, MD
The outbreak of the SARS-CoV-2 virus is disrupting rheumatology clinics and practices all over the world. In the U.S., many providers are turning to telemedicine to care for their patients, but struggles remain. Philip A. Waller, MD, who practices at Accurate Clinical Research, Houston, spoke with The Rheumatologist about how the pandemic is affecting his…
ACR Urges Commercial Payers to Provide Relief from Prior Authorizations, Practice Disruptions
The ACR is urging insurance companies to expand access to telehealth services and provide relief from administrative burdens to help providers focus on patient care at this critical time.
- « Previous Page
- 1
- …
- 65
- 66
- 67
- 68
- 69
- …
- 112
- Next Page »